Effects of the Tyrosine Kinase Inhibitor Imatinib on Neuroendocrine Tumor Cell Growth

Publisher： Karger

E-ISSN： 1421-9867|71|3|131-140

ISSN： 0012-2823

Source： Digestion, Vol.71, Iss.3, 2005-06, pp. : 131-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth

By Shushan Asher  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1957-1967

Oxford University Press

Access to resources Recommend Favorite

Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis

By Akashi Naotsugu  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 267-275

Springer Publishing Company

Access to resources Recommend Favorite

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo , but has little effect on existing tumor vessels

By Osusky Katherine  

Angiogenesis, Vol. 7, Iss. 3, 2004-09 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite

Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 159-167

Bentham Science Publishers

Access to resources Recommend Favorite

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

By Drevs J.  

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite